Society Advocates to Medicare about Physician Payment and Telehealth

The Endocrine Society continues to advocate for physician payment and telehealth policies important to Society members.

In September, the Society submitted comments on the Medicare Physician Fee Schedule (MPFS) proposed rule for calendar year 2022. This annual rule updates payment policies and payment rates for Part B services furnished under the MPFS. In our letter, we provided comments on a wide range of policies proposed under the rule including the need for expanded access to telehealth services. We urged CMS to work towards making coverage of audio-only services permanent by releasing the utilization data that has been gathered on audio-only during the public health emergency (PHE). Releasing this data will help the Society work with CMS to address fraud and abuse concerns which have prevented expansion of audio-only telehealth.

In addition to telehealth, we also urged CMS to re-evaluate their proposed changes to practice expense (PE) values which will impact a wide range of services commonly billed by endocrinologists. The changes proposed under the rule could result in decreases to services such as traditional continuous glucose monitoring and fine needle aspiration. Society staff worked closely with the Clinical Affairs Core Committee (CACC) in drafting our comments. The proposed rule is expected to be finalized later this year and we will share an update with you when the final rule is published. In the meantime, if you’re interested in reading our comment letter, please visit the Society Letters page.

You may also like

  • Endocrine Society Advocacy Updates

    Endocrine Society Endorses Right to IVF Act  In June 2024, the Endocrine Society endorsed the Right to IVF Act, introduced by Senators Cory Booker (D-NJ), Patty Murray (D-WA), and Tammy Duckworth (D-IL) to protect and expand nationwide access to fertility treatment, including in vitro fertilization (IVF). The Right to IVF Act would help individuals and families…

  • August 2024 Endocrine Society Advocacy Update

    Revised Version of TROA Passes House Ways & Means Committee On June 27, 2024, the House Ways and Means Committee passed a revised version of the Treat and Reduce Obesity Act (TROA), legislation that would allow Medicare coverage of anti-obesity medications (AOMs), which currently is prohibited under law. The version that passed would only allow…

Find more in